Triple-negative breast cancer (TNBC), a distinct form of breast cancer, is identified by the lack of estrogen receptor (ER), human epidermal growth factor receptor type 2 (HER2), and progesterone receptor (PR) expression (1). This evidence concerns the gene PGR and triple-negative breast carcinoma.